Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

Author： Hebenstreit Karin   Iacobelli Simona   Leiblein Sabine   Eisfeld Ann-Kathrin   Pfrepper Christian   Heyn Simone   Vucinic Vladan   Franke Georg-Nikolaus   Krahl Rainer   Fricke Stephan   Becker Cornelia   Pönisch Wolfram   Behre Gerhard   Niederwieser Dietger   Lange Thoralf  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1274-1280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma

By Satoh M.   Miyamura K.   Yamada M.   Ishidoya S.   Childs R.W.   Arai Y.  

Lancet Oncology, Vol. 5, Iss. 2, 2004-02 ,pp. : 125-126

Elsevier

Access to resources Recommend Favorite

B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn

By Herishanu Yair  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1125-1126

Informa Healthcare

Access to resources Recommend Favorite

Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome

By Montillo Marco   Schinkoethe Timo   Elter Thomas  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 488-496

Informa Healthcare

Access to resources Recommend Favorite

B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case–control study in Greece

By Dalamaga Maria  

Cancer Causes and Control, Vol. 21, Iss. 9, 2010-09 ,pp. : 1451-1459

Springer Publishing Company

Access to resources Recommend Favorite

Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia

By Lundin Jeanette   Karlsson Claes   Celsing Fredrik  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 137-139

Humana Press, Inc

Access to resources Recommend Favorite